Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas

Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas

The introduction of targeted therapy drugs into the practice of oncology urologists has improved the results of treatment of patients with metastatic clear-cell renal cell carcinomas (mCCRCC). Correctly chosen elements of systemic therapy will help specialist to control the course of the metastatic...

Full description

Bibliographic Details
Main Authors:	P S Borisov, R V Orlova, M I Shkolnik, P A Karlov
Format:	Article
Language:	Russian
Published:	IP Habib O.N. 2015-12-01
Series:	Современная онкология
Subjects:	metastatic clear-cell renal cell carcinomas incomplete ectomy for metastasis incomplete cytoreduction cytoreductive surgical intervention palliative treatment for metastatic kidney cancer combined treatment for metastatic kidney cancer targeted therapy cytokine therapy sorafenib sunitinib everolimus axitinib interferon a
Online Access:	https://modernonco.orscience.ru/1815-1434/article/view/27018

Similar Items

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results
by: Gaetano Facchini, et al.
Published: (2019-08-01)

Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
by: Yan Song, et al.
Published: (2016-01-01)

Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma?
by: Alex Renner, et al.
Published: (2019-03-01)

Health-Related Quality of Life following Cytoreductive Radical Prostatectomy in Patients with De-Novo Oligometastatic Prostate Cancer
by: Michael Chaloupka, et al.
Published: (2021-11-01)

An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer
by: Takafumi Yanagisawa, et al.
Published: (2023-02-01)

The role of active surveillance and cytoreductive nephrectomy in metastatic renal cell carcinoma
by: Amanda Nizam, et al.
Published: (2020-01-01)

A Case of Metastatic Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome-Associated Renal Cell Carcinoma Treated with a Sequence of Axitinib and Nivolumab Following Cytoreductive Nephrectomy
by: Ichiro Yonese, et al.
Published: (2020-07-01)

Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy—Data from the National Renis Registry
by: Alexandr Poprach, et al.
Published: (2020-10-01)

Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
by: Cheng Li, et al.
Published: (2021-08-01)

Cytoreductive Nephrectomy and Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives
by: Luigi Napolitano, et al.
Published: (2023-04-01)

Cytoreductive radiotherapy combined with abiraterone in metastatic castration-resistance prostate cancer: a single center experience
by: Yang Liu, et al.
Published: (2021-01-01)

New Paradigms for Cytoreductive Nephrectomy
by: Benjamin J. Lichtbroun, et al.
Published: (2022-05-01)

A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy
by: Hiroaki Sato, et al.
Published: (2023-05-01)

Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional study
by: Dae Keun Kim, et al.
Published: (2018-01-01)

Cytoreductive nephrectomy for synchronous metastatic renal cell carcinoma. Is there enough evidence?
by: Stamatios Katsimperis, et al.
Published: (2022-12-01)

Colorectal cancer with synchronous distant metastases: rationale for cytoreductive surgery and its perspectives – a surgeons view
by: V. A. Aliyev, et al.
Published: (2015-02-01)

Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature
by: Scott J. Dawsey, et al.
Published: (2021-05-01)

Can Incomplete Metastasectomy Impact Renal Cell Carcinoma Outcomes? A Propensity Score Matching Analysis From a Prospective Multicenter Collaboration
by: Alice Dragomir, Charles Hesswani, Gautier Marcq, Alan I So, Christian Kollmannsberger, Naveen S. Basappa, Adrian Fairey, Anil Kapoor, Aly-Khan A. Lalani, Antonio Finelli, Lori A Wood, Daniel Y.C. Heng, Georg Bjarnason, Rodney H. Breau, Luke T. Lavallée, Denis Soulières, Darrel Drachenberg, Frédéric Pouliot, Simon Tanguay
Published: (2021-03-01)

Conditional survival of metastatic clear cell renal cell carcinoma: How prognosis evolves after cytoreductive surgery of primary tumor
by: Haixiang Shen, et al.
Published: (2021-11-01)

Survival for patients with metastatic colon cancer underwent cytoreductive colectomy in the era of rapid development of anticancer drugs: A real-world analysis based on updated population dataset of 2004–2018
by: Guangran Meng, et al.
Published: (2022-10-01)

Outcomes of axitinib versus sunitinib as first‐line therapy to patients with metastatic renal cell carcinoma in the immune‐oncology era
by: Kazuyuki Numakura, et al.
Published: (2021-09-01)

More than 10 years survival with sequential therapy in a patient with advanced renal cell carcinoma: a case report
by: J.L. Yuan, et al.
Published: (2014-10-01)

More than 10 years survival with sequential therapy in a patient with advanced renal cell carcinoma: a case report
by: J.L. Yuan, et al.
Published: (2015-01-01)

The use of a new combination of avelumab + axitinib in patients with metastatic kidney cancer in the first line of treatment
by: B. Ya. Alekseev, et al.
Published: (2021-06-01)

The impact of cytoreductive nephrectomy on survival outcomes in patients with metastatic renal cell carcinoma receiving immunotherapy: An evidence-based analysis of comparative outcomes
by: Kun-peng Li, et al.
Published: (2023-03-01)

Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry
by: Radek Lakomy, et al.
Published: (2017-12-01)

TARGET THERAPY IN PATIENTS OF LIVER METASTATIC CANCER PATIENTS IN REAL CLINICAL PRACTICE
by: B. Y. ALEXEEV, et al.
Published: (2016-12-01)

Machine learning to improve prognosis prediction of metastatic clear-cell renal cell carcinoma treated with cytoreductive nephrectomy and systemic therapy
by: Wenjie Yang, et al.
Published: (2023-05-01)

Pazopanib in the treatment of advanced renal cell carcinoma
by: M. I. Volkova, et al.
Published: (2018-11-01)

Long-term outcomes after cytoreductive nephrectomy and thrombectomy of patients with metastatic renal cell carcinoma with venous tumor thrombus: a retrospective study from a large Chinese center
by: Kewei Chen, et al.
Published: (2023-06-01)

Quaternary and beyond cytoreduction: An updated and expanded analysis
by: Beryl L. Manning-Geist, et al.
Published: (2021-08-01)

CURRENT TREATMENT POLICY FOR RECTAL CANCER WITH SYNCHRONOUS DISTANT METASTASES (A CLINICAL CASE)
by: M. I. Davydov, et al.
Published: (2015-02-01)

Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
by: Cheng-Yuan Gu, et al.
Published: (2021-10-01)

Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study
by: Yoshifumi Kadono, et al.
Published: (2023-05-01)

Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not
by: Otto Hemminki, et al.
Published: (2020-12-01)

Hyperthermic intraperitoneal chemotherapy in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei: a 10-year treatment experience in China
by: Bing Wang, et al.
Published: (2024-01-01)

Establishment and validation of a nomogram to select patients with metastatic sarcomatoid renal cell carcinoma suitable for cytoreductive radical nephrectomy
by: Yulin Zhou, et al.
Published: (2023-10-01)

Advances in Cytoreductive Surgery and Combination Therapy for Ovarian Cancer
by: Xiaolan Lv, et al.
Published: (2022-07-01)

Health-related quality of life of metastatic prostate cancer patients treated with prostate Radiotherapy
by: Heba Maged Ayoub, et al.
Published: (2023-10-01)

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial
by: Laura Iisager, et al.
Published: (2024-02-01)